Search results
Found 10511 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
Translational Dermatology Unit
MRC TIDU
The aim of the group is to understand, at the molecular and cellular level, the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. We have a particular focus on T cells which recognise inflammatory lipids presented by CD1a. As well as contributing to an understanding of disease pathogenesis, we aim to translate our findings to changes in clinical practice.
RAMADAN GROUP
DNA Damage Response
D'ANGIOLELLA GROUP
Cell Cycle and Ubiquitin Signalling
Dong Group | T cell responses against Viruses & Cancer
MRC TIDU
Our group focuses on determining the factors which affect T cells both in the control of viral infection and in the development of cancer.
Kusumbe Lab | Tissue and Tumor Microenvironments
MRC TIDU
We Study Vascular Changes Over Time With The Aim To Treat Diseases
Koohy Group: Machine Learning and Integrative Approaches in Immunology
Centre for Computational Biology MRC TIDU
We would like to understand the functional and molecular mechanisms of the immune system in various immunologically important conditions such as cancer, infection, autoimmune disease as well as ageing. We have a special interest in computational cancer immunotherapy such as antigen presentation, neo-antigen identification and T cell recognition of neo-antigens as well as interrogating the immune response to personalized vaccines from neo-antigens.
Wilkinson Group: Blood Stem Cell Expansion and Fitness
MRC MHU
Haematopoietic stem cells (HSCs) support blood cell production throughout life and are also used clinically in cell and gene therapies. We are studying the biology of this important stem cell population with the aim of developing new HSC-based therapies.
Sahakyan Group: Integrative Computational Biology and Machine Learning
Centre for Computational Biology
Combining computational biology, computational chemistry, and machine learning techniques with biological big data to unravel the higher genomic code of life.
de Bruijn Group: Developmental Haematopoiesis
MRC MHU
We study the embryonic origins of blood stem cells with the aim to inform the generation of these cells in culture, and ultimate produce clinically relevant blood stem cells for therapeutic purposes.
Psaila Group: Normal and Malignant Megakaryocyte and Platelet Biology
MRC MHU
We apply state-of-the-art approaches to study normal and malignant megakaryocyte biology and bone marrow fibrosis, to identify new targets for therapy for patients with myeloproliferative neoplasms. We are also interested in the role of platelets as biomarkers for early cancer detection.